Compares treatment options for Piriformis Syndrome
Official title Effects of Reciprocal Inhibition Versus Post Facilitation Muscle Energy Technique Along With Conventional Physical Therapy in Patients With Piriformis Syndrome: a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06534788
What this study is testing
- What it's testing
- This study is a randomized controlled trial and the purpose of this study is to compare the effects of reciprocal inhibition versus post facilitation muscle energy technique along with conventional physical therapy in patients with piriformis syndrome in terms of pain, range of motion at hip joint and functional disability.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50
You may be able to join if
- Age: 20-50 years
- Both Genders
- Chronic pain in buttock and hip area (≥ 3 on NPRS) lasting more than 3 months.
- Shortened piriformis muscle (Internal rotation less than 30°) on muscle length assessment.
- A score of ≥ 8 on a 12-point clinical scoring system.
You likely can't join if
- Active infection
- Lower lumbar radiculopathy
- Sacroiliac joint dysfunction
- Malignancies
- History of trauma
- Hip Arthroplasty
See the full eligibility criteria
- Age: 20-50 years
- Both Genders
- Chronic pain in buttock and hip area (≥ 3 on NPRS) lasting more than 3 months.
- Shortened piriformis muscle (Internal rotation less than 30°) on muscle length assessment.
- A score of ≥ 8 on a 12-point clinical scoring system.
- At least two positive screening tests.
- Active infection
- Lower lumbar radiculopathy
- Sacroiliac joint dysfunction
- Malignancies
- History of trauma
- Hip Arthroplasty
- Rheumatoid/ Osteoarthritis
- Any neurological dysfunction
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.